Biologics CDMO Services Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Biologics CDMO Services's estimated annual revenue is currently $17.1M per year.(i)
  • Biologics CDMO Services's estimated revenue per employee is $155,000

Employee Data

  • Biologics CDMO Services has 110 Employees.(i)
  • Biologics CDMO Services grew their employee count by 0% last year.

Biologics CDMO Services's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
CEOReveal Email/Phone
3
SVP Process Development (Mammalian & Plasmid) and Manufacturing (Plasmid)Reveal Email/Phone
4
VP, Facilities & EngineeringReveal Email/Phone
5
ControllerReveal Email/Phone
6
Head Cell CultureReveal Email/Phone
7
VP, QualityReveal Email/Phone
8
VP - Corporate Planning and StrategyReveal Email/Phone
9
Director Business Development OperationsReveal Email/Phone
10
Director Business Development, Western USReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Biologics CDMO Services?

Bionova Scientific is a dynamic, full service, biologics Contract Development and Manufacturing Organization (CDMO) on a mission to deliver the highest quality process development and manufacturing services to biologic drug development companies around the world. Bionova's renowned scientific expertise and dedication to its customers helps life changing therapies arrive to the market faster and more efficiently. At the heart of Bionova is a team of highly dedicated experts combining strong experience in cGMP biologics manufacturing and process development, with a technology-focused approach and a deep knowledge of the industry. From early stage research material generation to Process Development and GMP manufacturing, Bionova's teams are fully committed to helping their clients fulfill their objective of providing sustainable and affordable therapies to their patients.

keywords:N/A

N/A

Total Funding

110

Number of Employees

$17.1M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Biologics CDMO Services News

2022-04-19 - The Global Contract Development and Manufacturing Organization Market Size to Surpass USD 143 Billion by 2027, States DelveInsight

... comprehensive solution to the biopharmaceutical companies for manufacturing biologic drugs. Additionally, the benefits of CDMO services...

2022-04-13 - Asahi Kasei enters biologics CDMO business in US deal

They are the ideal organization to serve as the foundation for our entry into the biopharmaceutical CDMO services,”? said Ken Shinomiya,...

2022-04-06 - Global Biologics CDMO Market is anticipated to witness a ...

Due to the complexities intrinsic to biologics development, biopharma companies look for a full-service CDMO handling all services,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$27M1105%N/A
#2
$16M11013%N/A
#3
$27.9M111-7%$22M
#4
$17.2M11125%$250M
#5
$23.5M11296%N/A